PDS Biotechnology Corp
PDSB· Nasdaq
Filed Feb 21, 2019 · 10-K · 52 days after period end · 0001140361-19-003636
derived · Computed from the longer spans the company filed.
| Metric | Q4 2018dderived from reported figures | Q4 2017 | Q4 2016 | Q4 2015 |
|---|---|---|---|---|
| Net Income | -$1.82M | -$13.91M | -$9.52M | -$7.96M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
ended Dec 31, 2018 · filed Feb 21, 2019 · 52 d after period end